Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0151744 (
myocardial ischemia
)
31,282
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We investigated the prevalence and characteristics of
ischemic heart disease
especially silent
myocardial ischemia
(SMI) and arrhythmia in need of careful observation in the exercise stress tests in the Total Health Promotion Plan (THP), which was conducted between 1994-96 for the purpose of measuring cardiopulmonary function. All workers (n = 4,918, 4,426 males) aged 18-60 yr old in an occupational field were studied. Exercise tests with an ergometer were performed by the LOPS protocol, in which the maximal workload was set up as a presumed 70-80% maximal oxygen intake, or STEP (original multistage protocol). ECG changes were evaluated with a CC5 lead. Two hundred and fifteen people refused the study because of a common cold, lumbago and so on. Of 4,703 subjects, 17 with abnormal rest ECG and 19 with probable anginal pain were excluded from the exercise tests. Of 4,667 who underwent the exercise test, 37 (0.79%) had ischemic ECG change, and 155 (3.32%) had striking arrhythmia. These 228 subjects then did a treadmill exercise test with Bruce protocol. Twenty-two (0.47% of 4,703) showed positive ECG change, 9 (0.19%) of 22 had abnormal findings on a 201Tl scan. 8 (0.17%) were diagnosed as SMI (Cohn I), in which the prevalence of hypertension, hyperlipidemia, diabetes mellitus, smoker and positive familial history of
ischemic heart disease
was greater than that of all subjects. In a 15-30 month follow up, none has developed cardiac accidents. Exercise-induced arrhythmia was detected in 11 (0.23%) subjects. Four were non-sustained ventricular tachycardia without any organic disease, 4 were ventricular arrhythmia based on cardiomyopathy detected by echocardiography, 2 were atrial fibrillation and another was
WPW syndrome
. It is therefore likely that the ergometer exercise test in THP was effective in preventing sudden death caused by
ischemic heart disease
or striking arrhythmia.
...
PMID:[Silent myocardial ischemia and exercise-induced arrhythmia detected by the exercise test in the total health promotion plan (THP)]. 1132 53
Inverted T waves produced by
myocardial ischemia
are classically narrow and symmetric. T-wave inversion (TWI) associated with an acute coronary syndrome (ACS) is morphologically characterized by an isoelectric ST segment that is usually bowed upward (ie, concave) and followed by a sharp symmetric downstroke. The terms coronary T wave and coved T wave have been used to describe these ischemic TWIs. Prominent, deeply inverted, and widely splayed T waves are more characteristic of non-ACS conditions such as juvenile T-wave patterns, left ventricular hypertrophy, acute myocarditis,
Wolff-Parkinson-White syndrome
, acute pulmonary embolism, cerebrovascular accident, bundle branch block, and later stages of pericarditis.
...
PMID:Electrocardiographic T-wave inversion: differential diagnosis in the chest pain patient. 1860 29
A 48-year-old woman with
Wolff-Parkinson-White syndrome
underwent surgical division of the accessory pathway in the left lateral wall. At 6 months after the procedure, she developed dyspnea and chest oppression. Coronary angiography revealed total occlusion in the left circumflex coronary artery (segment 13) at the exact site where cryoablation had been performed. The coronary occlusion was treated with an intracoronary bolus injection of urokinase (960,000 U) and subsequent percutaneous transluminal balloon angioplasty. No significant residual stenosis remained after the balloon angioplasty, and no further evidence of
myocardial ischemia
was noted for 13 years to date after the procedure.
...
PMID:Myocardial infarction after cryoablation surgery for Wolff-Parkinson-White syndrome. 1204 14
Atrioventricular node blocking agents including beta-adrenergic blockers, non-dihydropyridine calcium channel blockers and digoxin are usually effective in controlling ventricular rate in atrial fibrillation and flutter. Intravenous beta-blockers and non-dihydropyridine calcium channel blockers are equally effective in rapidly controlling the ventricular rate. The addition of digoxin to the regimen causes a favorable outcome but digoxin as a single agent is generally less effective in slowing the ventricular rate in acute setting. Clonidine, magnesium, and amiodarone have also been used for acute ventricular rate control in atrial fibrillation. Limited data suggest that combination regimens provide better ventricular rate control than any agent alone. The agent of first choice is usually individualized depending upon the clinical situation. Beta-blockers are preferable in patients with
myocardial ischemia
, myocardial infarction and hyperthyroidism and in post-operative state, but should be avoided in patients with bronchial asthma and chronic obstructive pulmonary disease where non-dihydropyridine calcium channel blockers are preferred. Beta-blockers are preferred drugs used for acute ventricular rate control in atrial fibrillation during pregnancy. In atrial fibrillation with
Wolff-Parkinson-White syndrome
, beta-blockers, calcium channel blockers and digoxin should be avoided, as these drugs are selective atrioventricular node blockers without slowing conduction through the accessory pathway, which can lead to increased transmission of impulses preferentially through the accessory pathway and precipitate ventricular fibrillation. The drug of choice for atrial fibrillation in pre-excitation syndrome is procainamide but propafenone, flecainide and disopyramide have also been used. When clinical condition is unstable or patient is hemodynamically compromised, immediate electrical cardioversion is the treatment of choice, as the best measure to control ventricular rate is by conversion to sinus rhythm. Factors precipitating rapid ventricular rate should be treated as well.
...
PMID:Acute ventricular rate control in atrial fibrillation and atrial flutter. 1533 99
The heart is capable of utilizing a variety of substrates to produce the necessary ATP for cardiac function. AMP-activated protein kinase (AMPK) has emerged as a key regulator of cellular energy homeostasis and coordinates multiple catabolic and anabolic pathways in the heart. During times of acute metabolic stresses, cardiac AMPK activation seems to be primarily involved in increasing energy-generating pathways to maintain or restore intracellular ATP levels. In acute situations such as mild ischemia or short durations of severe ischemia, activation of cardiac AMPK appears to be necessary for cardiac myocyte function and survival by stimulating ATP generation via increased glycolysis and accelerated fatty acid oxidation. Whereas AMPK activation may be essential for adaptation of cardiac energy metabolism to acute and/or minor metabolic stresses, it is unknown whether AMPK activation becomes maladaptive in certain chronic disease states and/or extreme energetic stresses. However, alterations in cardiac AMPK activity are associated with a number of cardiovascular-related diseases such as pathological cardiac hypertrophy,
myocardial ischemia
, glycogen storage cardiomyopathy, and
Wolff-Parkinson-White syndrome
, suggesting the possibility of a maladaptive role. Although the precise role AMPK plays in the diseased heart is still in question, it is clear that AMPK is a major regulator of cardiac energy metabolism. The consequences of alterations in AMPK activity and subsequent cardiac energy metabolism in the healthy and the diseased heart will be discussed.
...
PMID:Role of AMP-activated protein kinase in healthy and diseased hearts. 1684 22
Chest pain is not an uncommon complaint among adolescents; however, it often leads them to seek emergency medical care. The variant angina (coronary artery spasm) with resulting acute
myocardial ischemia
is an extremely rare cause of chest pain among the pediatric population, and there are very few cases reported. We describe a 13-year-old boy with underlying intermittent
Wolff-Parkinson-White syndrome
and who had an acute coronary artery syndrome due to coronary artery vasospasm.
...
PMID:Variant angina in an adolescent coexisting with intermittent Wolff-Parkinson-White syndrome. 1892 73
Electrocardiography is one of most classical methods of examination in medicine and in cardiology. After more than 100 years of practical use, it is indispensable in diagnosing arrhythmias as well as several, clinically important proarrhythmic states. In those, the heart with normal anatomy endangers the patient with the risk of serious, frequently life threatening arrhythmias (Long QT Syndrome, Brugada Syndrome,
Wolff-Parkinson-White Syndrome
, T-wave alternans). Further, electrocardiography is nowadays important in diagnosing the very fresh signs of
myocardial ischemia
. Present time electrocardiography is demanding for manufacturers of electrocardiographic machines, and requires precise, standard technique of examination. Despite automatic evaluation programmes of electrocardiogram, which are nowadays almost a standard, physicians should understand well the electrocardiogram, and must be able to correct frequent inaccuracies of the automatic evaluations.
...
PMID:[Electrocardiography of yesterday and today]. 1989 19
It is important to recognise
Wolff-Parkinson-White (WPW) syndrome
in electrocardiograms (ECG), as it may mimic
ischaemic heart disease
, ventricular hypertrophy and bundle branch block. In addition, ECG can aid in the localisation of the accessory pathway. Recognising
WPW syndrome
allows for risk stratification, the identification of associated conditions and the institution of appropriate management.
...
PMID:ECG delta waves in patients with palpitation. 2137 29
Background. It is important to recognise
Wolff-Parkinson-White (WPW) syndrome
in electrocardiograms (ECG), as it may mimic
ischaemic heart disease
, ventricular hypertrophy, and bundle branch block. Recognising
WPW syndrome
allows for risk stratification, the identification of associated conditions, and the institution of appropriate management. Objective. The present case showed that electrophysiological study is indicated in patients with abnormal ECG and syncope. Case Report. A 40-year-old man with
Wolff-Parkinson-White syndrome
was presented to emergency with syncope. A baseline ECG was a complete right branch block and posterior left hemiblock. He was admitted to the cardiac care unit for pacemaker implantation. The atypical figure of complete right branch block and posterior left hemiblock was thought to be a "false positive" of conduction abnormality. But the long anterograde refractory period of the both accessory pathway and atrioventricular conduction may cause difficulty in diagnosing
Wolff-Parkinson-White syndrome
, Conclusion. A
Wolff-Parkinson-White Syndrome
may mimic a conduction disease. No reliable algorithm exists for making an ECG diagnosis of a preexcitation syndrome with conduction disorders. This can lead to diagnostic and therapeutic dilemmas in the context of syncope.
...
PMID:Wolff-Parkinson-white syndrome mimics a conduction disease. 2511 86
Radiofrequency catheter ablation (RFCA) procedure is performed for many tachyarrhythmias. We performed successful RFCA in a 5-year-old child for supraventricular tachyarrhythmia and
Wolff-Parkinson-White syndrome
. Acute circumflex artery (CxA) occlusion occurred due to RFCA. After percutaneous balloon angioplasty was performed into the CxA, the patient was treated with systemic steroid to resolve myocardial edema. To the best of our knowledge, systemic steroid was used first time for acute coronary artery injury related
myocardial ischemia
.
...
PMID:An unusual treatment of coronary injury following radiofrequency ablation in a 5-year-old child: Systemic steroid usage. 3254 18
<< Previous
1
2
3